Literature DB >> 31408804

Hemodynamic decompensation in normotensive patients admitted to the ICU with pulmonary embolism.

Het Patel1, Jenny A Shih2, Ryan Gardner3, Parth V Patel4, Catherine Ross5, Margaret M Hayes6, Ari Moskowitz7, Michael W Donnino8.   

Abstract

PURPOSE: Many normotensive patients with acute pulmonary embolism (PE) are admitted to an intensive care unit (ICU) to monitor for hemodynamic decompensation. We investigated the incidence and causes of early hemodynamic decompensation in normotensive patients admitted to an ICU with PE.
MATERIALS AND METHODS: This was a single-center, retrospective study of normotensive patients admitted to an ICU with primary diagnosis of PE between 2010 and 2017. The primary outcome was hemodynamic decompensation, defined as need for vasopressors within 48 h of ICU admission.
RESULTS: Of 293 patients included in the study, hemodynamic decompensation occurred in 8 patients (2.7%). The two most common precipitants of hemodynamic decompensation were acute hemorrhage and PE-related right ventricular dysfunction - each contributing to hemodynamic decompensation in 3 patients.
CONCLUSIONS: Among patients admitted to the ICU with acute normotensive PE, early hemodynamic decompensation was rare. In patients who experienced decompensation, major bleeding and thrombotic complications were equally likely to have been the precipitant- highlighting the risks of diagnostic anchoring in this population. As our results suggest that ICU-level care may not be necessary for many of these patients, additional tools are needed to assist in the triage of normotensive patients with PE.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Critical care; Precipitants of decompensation; Pulmonary Embolism; Shock

Mesh:

Substances:

Year:  2019        PMID: 31408804      PMCID: PMC7146081          DOI: 10.1016/j.jcrc.2019.07.017

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  17 in total

1.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

Review 2.  The epidemiology of deep vein thrombosis and pulmonary embolism.

Authors:  E Ascari; S Siragusa; F Piovella
Journal:  Haematologica       Date:  1995 Mar-Apr       Impact factor: 9.941

3.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

4.  Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Authors:  Guy Meyer; Eric Vicaut; Thierry Danays; Giancarlo Agnelli; Cecilia Becattini; Jan Beyer-Westendorf; Erich Bluhmki; Helene Bouvaist; Benjamin Brenner; Francis Couturaud; Claudia Dellas; Klaus Empen; Ana Franca; Nazzareno Galiè; Annette Geibel; Samuel Z Goldhaber; David Jimenez; Matija Kozak; Christian Kupatt; Nils Kucher; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Gerard Pacouret; Massimiliano Palazzini; Antoniu Petris; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Sebastian Schellong; Mustapha Sebbane; Bozena Sobkowicz; Branislav S Stefanovic; Holger Thiele; Adam Torbicki; Franck Verschuren; Stavros V Konstantinides
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

5.  Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.

Authors:  Joyce C LaMori; Omar Shoheiber; Samir H Mody; Brahim K Bookhart
Journal:  Clin Ther       Date:  2014-12-15       Impact factor: 3.393

6.  Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry.

Authors:  W Kasper; S Konstantinides; A Geibel; M Olschewski; F Heinrich; K D Grosser; K Rauber; S Iversen; M Redecker; J Kienast
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

7.  Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.

Authors:  Silvy Laporte; Patrick Mismetti; Hervé Décousus; Fernando Uresandi; Remedios Otero; Jose Luis Lobo; Manuel Monreal
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

8.  Hospital-level variation in ICU admission and critical care procedures for patients hospitalized for pulmonary embolism.

Authors:  Andrew J Admon; Christopher W Seymour; Hayley B Gershengorn; Hannah Wunsch; Colin R Cooke
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

9.  Characteristics, incidence and outcome of patients admitted to intensive care because of pulmonary embolism.

Authors:  Dario Winterton; Michael Bailey; David Pilcher; Giovanni Landoni; Rinaldo Bellomo
Journal:  Respirology       Date:  2016-09-11       Impact factor: 6.424

10.  Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism.

Authors:  David Jiménez; Dita Kopecna; Victor Tapson; Beau Briese; Donald Schreiber; José Luis Lobo; Manuel Monreal; Drahomir Aujesky; Olivier Sanchez; Guy Meyer; Stavros Konstantinides; Roger D Yusen
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

View more
  1 in total

Review 1.  Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review.

Authors:  Catherine Ross; Riten Kumar; Marie-Claude Pelland-Marcotte; Shivani Mehta; Monica E Kleinman; Ravi R Thiagarajan; Muhammad B Ghbeis; Christina J VanderPluym; Kevin G Friedman; Diego Porras; Francis Fynn-Thompson; Samuel Z Goldhaber; Leonardo R Brandão
Journal:  Chest       Date:  2021-09-26       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.